- Home
- MRM vs CPIX Comparison
MRM vs CPIX Comparison
Compare MRM & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRM
- CPIX
- Stock Information
- Founded
- MRM 2000
- CPIX 1999
- Country
- MRM Japan
- CPIX United States
- Employees
- MRM N/A
- CPIX N/A
- Industry
- MRM Other Consumer Services
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- MRM Consumer Discretionary
- CPIX Health Care
- Exchange
- MRM Nasdaq
- CPIX Nasdaq
- Market Cap
- MRM 5.9M
- CPIX 68.7M
- IPO Year
- MRM 2020
- CPIX 2009
- Fundamental
- Price
- MRM $1.36
- CPIX $2.81
- Analyst Decision
- MRM
- CPIX
- Analyst Count
- MRM 0
- CPIX 0
- Target Price
- MRM N/A
- CPIX N/A
- AVG Volume (30 Days)
- MRM 44.6K
- CPIX 87.8K
- Earning Date
- MRM 05-20-2025
- CPIX 08-05-2025
- Dividend Yield
- MRM N/A
- CPIX N/A
- EPS Growth
- MRM 27.65
- CPIX N/A
- EPS
- MRM 0.18
- CPIX N/A
- Revenue
- MRM $52,786,758.00
- CPIX $41,083,299.00
- Revenue This Year
- MRM N/A
- CPIX N/A
- Revenue Next Year
- MRM N/A
- CPIX N/A
- P/E Ratio
- MRM $7.44
- CPIX N/A
- Revenue Growth
- MRM 21.55
- CPIX 5.82
- 52 Week Low
- MRM $0.34
- CPIX $1.04
- 52 Week High
- MRM $8.39
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- MRM 49.70
- CPIX 28.15
- Support Level
- MRM $1.32
- CPIX $2.51
- Resistance Level
- MRM $1.50
- CPIX $5.68
- Average True Range (ATR)
- MRM 0.09
- CPIX 0.58
- MACD
- MRM -0.05
- CPIX -0.36
- Stochastic Oscillator
- MRM 18.92
- CPIX 4.52
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.